Rock Springs Capital Management LP Q2 2021 Filing
Filed August 16, 2021
Portfolio Value
$5.1B
Holdings
156
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (156 positions)
| Stock | Value |
|---|---|
AGLAGILON HEALTH INC | $283.9M |
ZLABZAI LAB LTD | $179.5M |
AGIOAGIOS PHARMACEUTICALS INC | $141.9M |
HUMHUMANA INC | $133.9M |
AFWALIGN TECHNOLOGY INC | $114.7M |
IDXXIDEXX LABS INC | $113.7M |
PODDINSULET CORP | $112.2M |
ISRGINTUITIVE SURGICAL INC | $110.4M |
NBIXNEUROCRINE BIOSCIENCES INC | $98.8M |
NVV1NOVAVAX INC | $96.6M |
UNHUNITEDHEALTH GROUP INC | $96.1M |
ARGXARGENX SE | $94.8M |
IMCRIMMUNOCORE HLDGS PLC | $93.5M |
HCAHCA HEALTHCARE INC | $93.0M |
NVROEURNEVRO CORP | $88.0M |
FRPTFRESHPET INC | $82.5M |
NVTA1EURINVITAE CORP | $77.6M |
2L9BLUEPRINT MEDICINES CORP | $71.1M |
EXASEXACT SCIENCES CORP | $70.9M |
ONCBEIGENE LTD | $68.6M |
GRPHGRAPHITE BIO INC | $66.1M |
ACRSACLARIS THERAPEUTICS INC | $66.1M |
PCRXPACIRA BIOSCIENCES INC | $62.2M |
EWEDWARDS LIFESCIENCES CORP | $60.3M |
PHRPHREESIA INC | $58.8M |
HZNPHORIZON THERAPEUTICS PUB L | $58.5M |
VERVVERVE THERAPEUTICS INC | $58.0M |
—EARGO INC | $57.9M |
TFXTELEFLEX INCORPORATED | $52.2M |
MRTXEURMIRATI THERAPEUTICS INC | $51.5M |
ALNYALNYLAM PHARMACEUTICALS INC | $50.9M |
PRTAPROTHENA CORP PLC | $48.8M |
ARVNARVINAS INC | $48.2M |
RAREULTRAGENYX PHARMACEUTICAL IN | $44.3M |
KRTXKARUNA THERAPEUTICS INC | $44.1M |
ACHCACADIA HEALTHCARE COMPANY IN | $43.9M |
HCATHEALTH CATALYST INC | $43.6M |
LFSTLIFESTANCE HEALTH GROUP INC | $41.8M |
SWAVUSDSHOCKWAVE MED INC | $41.7M |
—BRIGHT HEALTH GROUP INC | $40.8M |
PENPENUMBRA INC | $40.4M |
ARDXARDELYX INC | $39.8M |
SGENUSDSEAGEN INC | $39.5M |
BIIBBIOGEN INC | $39.3M |
CVETUSDCOVETRUS INC | $39.3M |
EHCENCOMPASS HEALTH CORP | $39.0M |
NVCRNOVOCURE LTD | $38.8M |
—MERSANA THERAPEUTICS INC | $38.6M |
ACCDEURACCOLADE INC | $36.1M |
EVHEVOLENT HEALTH INC | $35.9M |
BSXBOSTON SCIENTIFIC CORP | $34.2M |
—PPD INC | $31.1M |
ASNDASCENDIS PHARMA A/S | $30.7M |
KYMRKYMERA THERAPEUTICS INC | $30.4M |
IRTCIRHYTHM TECHNOLOGIES INC | $29.7M |
CGEMCULLINAN ONCOLOGY INC | $27.7M |
ADPTADAPTIVE BIOTECHNOLOGIES COR | $26.6M |
MIRMMIRUM PHARMACEUTICALS INC | $26.3M |
LUNGPULMONX CORP | $26.1M |
ALLKGUSDALLAKOS INC | $26.1M |
CERE1EURCEREVEL THERAPEUTICS HLDNG I | $26.1M |
MDGLMADRIGAL PHARMACEUTICALS INC | $25.6M |
SRPTSAREPTA THERAPEUTICS INC | $25.6M |
BOLT1EURBOLT BIOTHERAPEUTICS INC | $25.0M |
—EPIZYME INC | $25.0M |
GHGUARDANT HEALTH INC | $24.8M |
ACADACADIA PHARMACEUTICALS INC | $24.4M |
CNMDCONMED CORP | $22.3M |
OSH3EUROAK STR HEALTH INC | $22.0M |
TVTXTRAVERE THERAPEUTICS INC | $21.8M |
COLLCOLLEGIUM PHARMACEUTICAL INC | $21.7M |
BMRNBIOMARIN PHARMACEUTICAL INC | $21.2M |
—ABCAM PLC | $20.9M |
—INTERSECT ENT INC | $20.9M |
RIGLUSDRIGEL PHARMACEUTICALS INC | $20.6M |
—SIERRA ONCOLOGY INC | $19.8M |
DC4DEXCOM INC | $19.5M |
INNVINNOVAGE HLDG CORP | $19.2M |
—TRANSLATE BIO INC | $19.1M |
AMRNAMARIN CORP PLC | $18.9M |
BMEABIOMEA FUSION INC | $18.2M |
SPRBSPRUCE BIOSCIENCES INC | $18.0M |
RCKTROCKET PHARMACEUTICALS INC | $17.9M |
KURAKURA ONCOLOGY INC | $17.0M |
AVIRATEA PHARMACEUTICALS INC | $17.0M |
CYTK 4 11/15/26CYTOKINETICS INC | $16.6M |
DVAXDYNAVAX TECHNOLOGIES CORP | $16.5M |
RLAYRELAY THERAPEUTICS INC | $16.5M |
NKTXNKARTA INC | $15.8M |
—CHIASMA INC | $15.4M |
—PROMETHEUS BIOSCIENCES INC | $14.6M |
—OLINK HLDG AB | $14.6M |
APLTAPPLIED THERAPEUTICS INC | $14.6M |
MREOMEREO BIOPHARMA GROUP PLC | $14.4M |
EPIEURESSA PHARMA INC | $14.4M |
INZYINOZYME PHARMA INC | $14.3M |
ANABANAPTYSBIO INC | $13.9M |
—GAMIDA CELL LTD | $13.5M |
SPROSPERO THERAPEUTICS INC | $13.5M |
AKROAKERO THERAPEUTICS INC | $13.1M |
Page 1 of 2Next